Abstract
Progress in understanding and treating hemolytic diseases of the fetus and newborn due to RhO(D) isoimmunization is well documented in the medical literature. Wysowski et al. (1979) noted that the incidence of Rh disease declined from 45 to 21 per 10,000 live births between 1970 and 1975. These data, from a birth defects screening program, if applied to all births in the United States, imply an estimated reduction in the number of newborn infants suffering from Rh isoimmunization from 16,000 to 6000. Similarly, the infant mortality from all hemolytic diseases of the newborn also decreased, from 2.7 per 10,000 live births (a total of 941 deaths) to 0.9 per 10,000 live births (a total of 269 deaths) by 1975. Successful management of erythroblastosis fetalis and almost complete prevention of Rh disease of the newborn are possibilities. To achieve these goals all health care providers must maintain up-to-date knowledge of current treatment and controversies. This chapter will therefore review three broad areas of concern: (1) Counseling the already sensitized patient who desires another pregnancy; (2) evaluation of new methods of management of the affected fetus; and (3) identification of the reproductive events that result in sensitization.
Deceased
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Acker, D. B., and Frigoletto, F. D., 1982, Rh-isoimmunization, Am. J. Obstet. Gynecol. 143:487.
Acker, D. B., Frigoletto, F. D., Birnholz, J. C., et al., 1980, Ultrasound-facilitated intrauterine transfusions, Am. J. Obstet. Gynecol. 138:1200.
Allen, F. J., Jr., 1954, Erythoblastosis fetalis. IX. The problems of stillbirth, 251:453.
Allen, F. H., and Umansky, I., 1972, Erythroblastosis fetalis, in: Principles and Management of Human Reproduction (D. E. Reid, K. J. Ryan, and K. Benirshke, eds.), p. 811, Saunders, Philadelphia.
Alpern, W. M., 1969, Spectrophotometric analysis of amniotic fluid, in: Rh Isoimmunization and Erythroblastosis Fetalis (A. G. Charles and E. A. Friedman, eds.), p. 114, Appleton-Century-Crofts, New York.
Barclay, G. R., Greiss, M. A., and Urbank, S. J., 1980, Adverse effect of plasma exchange on anti-D production in rhesus immunization owing to removal of inhibitory factors, Br. Med. J. 280:1569.
Bevis, D. C. A., 1952, The antenatal prediction of haemolytic disease of the newborn, Lancet 1:395.
Bevis, D. C. A., 1953, The composition of liquor amnii in haemolytic disease of the newborn, J. Obstet. Gynaecol. Br. Emp. 60:244.
Bevis, D. C. A., 1956, Blood pigments in haemolytic disease of the newborn, J. Obstet. Gynecol. Br. Emp. 63:68.
Bock, J. E., and Winkel, S., 1976, Follow-up study on infants who received intrauterine transfusions because of severe rhesus hemolytic disease, Acta Obstet. Gynecol. Scand. (Suppl.) 53:37.
Bowman, J. M., 1967, Neonatal Management, in: Modern Management of the Rh Problem (J. T. Queenan, ed.), p. 267, Hoeber, New York.
Bowman, J. M., 1975, Rh erythroblastosis fetalis 1975, Curr. Probl. Pediatr. Hematol. 1975:29.
Bowman, J., 1976, Winnepeg antenatal prophylaxis trial, in: Symposium on Rh Antibody Mediated Immunosuppression, p. 55, Ortho Diagnostics, Raritan, New Jersey.
Bowman, J. M., 1978a, Suppression of isoimmunization: A review, Obstet. Gynecol. 52:385.
Bowman, J. M., 1978b, The management of Rh isoimmunization, Obstet. Gynecol. 52:1.
Buchanan, D. I., Bell, R. E., Beck, R. P., et al., 1969, Use of different doses of anti-Rh isoimmunisation, Lancet 2:288.
Cooperberg, P. L., and Carpenter, C. W., 1977, Ultrasound as an aid in intrauterine transfusion, Am. J. Obstet. Gynecol. 128:239.
Cooperberg, P. L., and Carpenter, C. W., 1978, Real time ultrasound as an aid in intrauterine transfusion, Radiology 127:535.
Fraser, I. D., Bothamley, J. E., Bennett, M. O., et al., 1976, Intensive antenatal plasmapheresis in severe rhesus isoimmunization, Lancet 1:6.
Freda, V. J., 1965, The Rh problem in obstetrics and a new concept of its management using amniocentesis and spectrophotometric scanning of amniotic fluid, Am. J. Obstet. Gynecol. 92:341.
Freda, V. J., Gorman, J. G., Pollack, W., et al., 1975, Prevention of Rh hemolytic disease: Ten years’ clinical experience with Rh immune globulin, N. Engl. J. Med. 292:1014.
Frigoletto, F. D., Birnholz, J. E., Rothchild, S. B., et al., 1978, Intrauterine transfusion with the use of phased array ultrasonography: A new technique, Am. J. Obstet. Gynecol. 131:273.
Graham-Pole, J., Barr, W., and Willoughby, M. L. N., 1977, Continuous-flow plasmapheresis in management of severe rhesus disease, Br. Med. J. 1:1185.
Grimes, D. A., Ross, W. C., and Hatcher, R. A., 1977, Rh immunoglobulin utilization after spontaneous and induced abortion, Obstet. Gynecol. 50:261.
Grimes, D. A., Geary, F. H., and Hatcher, R. A., 1981, Rh-immunoglobulin utilization after ectopic pregnancy, Am. J. Obstet. Gynecol. 140:246.
Hamilton, E. G., 1977, Intrauterine transfusion, Obstet. Gynecol. 50:255.
Hensleigh, P. A., Leslie, W., Dixon, E. Hall, E., Kitay, D. Z., and Jackson, J. E., 1977, Reduced dose of RhQ(D) immune globulin following induced first-trimester abortion, Obstet. Gynecol. 50:261.
Hobbins, J. C., Davis, E. D., and Webster, J., 1975, A new technique utilizing ultrasound to aid in IUT, J. Clin. Ultrasound 4:135.
Katz, J., and Marcus, R. G., 1972, The risk of Rh-isoimmunization in ruptured tubal pregnancy, Br. Med. J. 3:667.
Liggens, G. C., 1966, Intrauterine Transfusion and Erythroblastosis, Report of the 53rd Ross Conference on Pediatric Research, Columbus, Ross Laboratories.
Liley, A. W., 1961, Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization, Am. J. Obstet. Gynecol. 82:1359.
Liley, A. W., 1963, Intrauterine transfusion in haemolytic disease, Br. Med. J. 2:1107.
Litwak, O., Taswall, H. F., Banner, E. A., et al., 1970, Fetal erythrocytes in maternal circulation after spontaneous abortion, J. Am. Med. Assoc. 214:531.
Lucey, J. F., 1968, Diagnosis and treatment: Current indications and results of fetal transfusions, Pediatrics 41:139.
Mollison, P. L., 1972, Blood transfusion in Clinical Medicine, 1st ed., p. 628, Blackwell, London.
Ogborn, A. D. R., Hunt, K. M., Gordon, H., 1977, Factors affecting fetal survival after intrauterine transfusion for rhesus isoimmunization, Br. J. Obstet. Gynaecol. 84:665.
Palmer, A., and Gordon, R. R., 1976, A critical review of intrauterine fetal transfusion, Br. J. Obstet. Gynaecol. 83:688.
Parkman, R., Mosier, D., Umansky, I., et al., 1971, Graft vs. host disease after intrauterine and exchange transfusion for hemolytic disease of the newborn, N. Engl. J. Med. 1290:359.
Queenan, J. T., 1966, Amniocentesis and transamniotic fetal transfusion for Rh disease, Clin. Obstet.Gynecol. 9:941.
Queenan, J. T., 1969, Intrauterine transfusion, Am. J. Obstet. Gynecol. 104:397.
Queenan, J. T., 1977, Intrauterine Transfusion, in: Modern Management of the Rh Problem, 2nd ed., p. 169, Hagerstown, Maryland.
Queenan, J. T., Shah, S., Kubarych, S. F., et al., 1971, Role of induced abortion in rhesus immunization, Lancet 1:815.
Robertson, E. G., Brown, A., Ellis, M. I., et al., 1976, Intrauterine transfusion in the management of severe rhesus isoimmunization, Br. J. Obstet. Gynaecol. 83:694.
Rodeck, C. L. H., Holman, C. A., Karnicki, J., et al., 1981, Direct intravascular fetal blood transfusion by fetoscopy in severe rhesus isoimmunization, Lancet 1:625.
Stewart, F. H., Burnhill, M. S., and Bozorgi, N., 1978, Reduced dose of Rh-immunoglobulin following first-trimester pregnancy termination, Obstet. Gynecol. 51:318.
Umansky, I., and Allen, F. H., 1972, Erythroblastosis fetalis, in: Principles and Management of HumanReproduction (D. E. Reid, K. J. Ryan, and K. Benirshke, eds.), p. 820, Saunders, Philadelphia.
Umansky, I., and Frigoletto, F. D., 1976, Current Uses of RhQ Immune Globulin and Detection of Antibodies, ACOG Technical Bulletin No. 35, January 1976.
Walsh, J.J. and Lewis, B. V, 1970, Transplacental haemorrhage due to termination of pregnancy, J. Obstet.Gynaecol. Br. Comm. 77:133.
Weinstein, L., 1982, Irregular antibodies causing hemolytic disease of the newborn: A continuing problem, Clin. Obstet. Gynecol. 25:321.
Whitfield, C. R., 1970, A three year assessment of an action line method of timing intervention in rhesus isoimmunization, Am. J. Obstet. Gynecol. 108:1239.
WHO, 1971, Prevention of Rh Sensitization, World Health Organization Technical Report Series, No. 468.
Wysowski, D. K., Flynt, W., Golldberg, M. F., et al., 1979, Rh hemolytic disease: Epidemiologic surveillance in the United States, 1968 to 1975, J. Am. Med. Assoc. 242:1376.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Aubrey Milunsky
About this chapter
Cite this chapter
Acker, D.B., Frigoletto, F.D., Umansky, I. (1986). Diagnosis, Treatment, and Prevention of Isoimmune Hemolytic Disease of the Newborn. In: Milunsky, A. (eds) Genetic Disorders and the Fetus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5155-9_26
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5155-9_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5157-3
Online ISBN: 978-1-4684-5155-9
eBook Packages: Springer Book Archive